Utah Retirement Systems Acadia Pharmaceuticals Inc Transaction History

Utah Retirement Systems

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$25.02 - $54.99 $142,614 - $313,443	-5,700 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $233,928 - $323,703	5,700 New	5,700 $305,000
Q3 2020 Nov 16, 2020	SELL	$36.42 - $57.0 $167,532 - $262,200	-4,600 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $180,596 - $242,558	4,600 New	4,600 $223,000
Q2 2018 Aug 10, 2018	SELL	$15.07 - $22.34 $275,781 - $408,822	-18,300 Closed	0 $0

Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $2,247 - $3,233	100 Added 0.55%	18,300 $411,000
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $13,420 - $19,570	500 Added 2.82%	18,200 $548,000
Q3 2017 Nov 13, 2017	BUY	$29.49 - $38.37 $521,973 - $679,149	17,700	17,700 $667,000

299

158M

1.88M

688K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.56B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

Stay updated on Utah Retirement Systems with notifications on news.